Five Value Stocks with Recovery Potential in 2026: PayPal (PYPL), Nike (NKE), and More

Key Takeaways

• PayPal (PYPL) guided for stagnant adjusted earnings in 2026, triggering a selloff, though turnaround opportunities persist
• CVS Health (CVS) delivered $402.1 billion in 2025 revenue and projects at minimum $400 billion for 2026
• Nike (NKE) generated $11.3 billion in third-quarter 2026 sales, with wholesale advancing 5% and North American operations improving
• HP (HPQ) announced first-quarter 2026 revenue of $14.4 billion, representing 6.9% annual growth, with projected free cash flow between $2.8 billion and $3.0 billion
• Estée Lauder (EL) saw shares decline following underwhelming fiscal 2026 outlook despite surpassing earnings projections

Investors searching for value opportunities in 2026 are closely monitoring five companies: PayPal, CVS Health, Nike, HP, and Estée Lauder.

These aren’t merely discounted equities. Each demonstrates a distinctive pattern: reserved market sentiment combined with tangible business drivers that could reshape their valuation narratives.

Companies Navigating Turnarounds

PayPal (PYPL)

PayPal represents perhaps the most transparent case of subdued expectations colliding with potential rebound momentum. According to Reuters reporting from February, the payment processor projected essentially flat or marginally declining adjusted earnings for 2026, falling short of analyst projections.

PayPal Holdings, Inc., PYPL

Shares tumbled significantly following executive transitions that sparked concerns about strategic implementation. However, should leadership successfully accelerate branded checkout adoption and enhance Venmo revenue generation, the equity might begin commanding valuations more aligned with a revitalizing fintech enterprise.

CVS Health (CVS)

CVS Health continues appearing underpriced when measured against its operational scale. The healthcare giant posted 2025 full-year sales totaling $402.1 billion. Leadership projected 2026 adjusted earnings per share ranging from $7.00 to $7.20, supported by revenues exceeding $400 billion.

CVS Health Corporation, CVS

The shares don’t require comprehensive recovery to appreciate. Sufficient margin expansion within its insurance and pharmacy segments could prompt investors to reassess it as a resilient cash-generating operation.

Nike (NKE)

Nike remains perceived by markets as a complicated turnaround situation with multiple challenges. The athletic apparel leader’s fiscal third-quarter 2026 results, disclosed March 31, showed $11.3 billion in revenue with wholesale channels climbing 5%. North American operations also posted gains.

NIKE, Inc., NKE

Gross profitability contracted, and certain business segments face ongoing headwinds. Nevertheless, selective areas are trending positively, which frequently signals the beginning of value-oriented opportunities.

Cash Generation and Rehabilitation Opportunities

HP (HPQ)

HP disclosed fiscal first-quarter 2026 sales of $14.4 billion, marking 6.9% year-over-year expansion. Non-GAAP diluted earnings per share increased 9.5%, while free cash flow registered $175 million. The technology company reaffirmed its annual free cash flow projection of $2.8 billion to $3.0 billion.

The optimistic scenario depends on stabilizing PC market conditions and accelerating traction in AI-enabled computers. HP doesn’t require explosive revenue acceleration to advance—merely sustained earnings stability.

Estée Lauder (EL)

Estée Lauder presents the greatest risk among these selections. Reuters indicated in February that shares retreated after fiscal 2026 guidance underwhelmed investors, despite earnings surpassing forecasts.

Executives outlined turnaround initiatives centered on product introductions, marketing investments, and premium brand positioning. Markets remain concerned about softening U.S. consumer demand, tariff pressures, and execution uncertainties.

Based on recent guidance, Estée Louder has yet to demonstrate sustained revenue momentum or profitability improvement.

Concluding Analysis

These five equities share a unifying characteristic. Market sentiment remains guarded, yet each possesses legitimate catalysts capable of transforming their 2026 valuations.

The post Five Value Stocks with Recovery Potential in 2026: PayPal (PYPL), Nike (NKE), and More appeared first on Blockonomi.